Pharmacodynamic Study of Pembrolizumab in Patients With Recurrent Glioblastoma
Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if Keytruda (pembrolizumab) can help to
control glioblastoma. The safety of this drug will also be studied.